Home Newsfeeds RBC Capital Downgrades Rackspace Tech to Sector Perform, Lowers Price Target to $7

RBC Capital Downgrades Rackspace Tech to Sector Perform, Lowers Price Target to $7

RBC Capital analyst Daniel Perlin downgrades Rackspace Tech (NASDAQ:RXT) from Outperform to Sector Perform and lowers the price target from $9 to $7.

byBenzinga Newsdesk

August 11, 2022

1 minute read

RBC Capital analyst Daniel Perlin downgrades Rackspace Tech (NASDAQ:RXT) from Outperform to Sector Perform and lowers the price target from $9 to $7.

Exxon Goes Big on New Fracking Tech: Eyeing Double Oil Production from US Shale

By Nabaparna Bhattacharya

June 2, 8:50 AM

Exxon Mobil Corporation (NYSE: XOM) is reportedly eyeing new fracking technologies to double the amount of oil produced from the company's U.S. Shale holdings over five years.

XOM

Silo Pharma Concludes First Phase of Dose-Ranging Study Of Intranasal Treatment For Post Traumatic Stress Disorder

By Vandana Singh

January 4, 9:55 AM

Thursday, Silo Pharma Inc (NASDAQ: SILO) provided an update on its previously announced dose-ranging study of SPC-15, a targeted prophylactic treatment for post-traumatic stress disorder (PTSD).

SILO

Why Symbotic Stock Surges After-Hours

By Ryan Gustafson

November 20, 6:05 PM

Symbotic Inc. (NASDAQ: SYM) shares are trading higher in Monday's after-hours session after the company reported better-than-expected fourth-qu

SYM

Reported Late Thursday March 2, Mirion Technologies Announces Pricing Of Public Offering Of 9,786,153 Shares At A Price Of $8.75/Share By Selling Stockholders

By Happy Mohamed

March 3, 1:29 AM

Mirion Technologies, Inc. ("Mirion," "we" or the "company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear,

MIR

RBC Capital Downgrades Rackspace Tech to Sector Perform, Lowers Price Target to $7

Related Posts

Exxon Goes Big on New Fracking Tech: Eyeing Double Oil Production from US Shale

Silo Pharma Concludes First Phase of Dose-Ranging Study Of Intranasal Treatment For Post Traumatic Stress Disorder

Why Symbotic Stock Surges After-Hours

Reported Late Thursday March 2, Mirion Technologies Announces Pricing Of Public Offering Of 9,786,153 Shares At A Price Of $8.75/Share By Selling Stockholders